Your browser doesn't support javascript.
loading
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Sherman, Matthew A; Graf, Rose; Sabbagh, Sara E; Galindo-Feria, Angeles S; Pinal-Fernandez, Iago; Pak, Katherine; Kishi, Takayuki; Flegel, Willy A; Targoff, Ira N; Miller, Frederick W; Lundberg, Ingrid E; Rider, Lisa G; Mammen, Andrew L.
Afiliação
  • Sherman MA; Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Graf R; Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Sabbagh SE; Division of Rheumatology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Galindo-Feria AS; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet.
  • Pinal-Fernandez I; Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Pak K; Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Kishi T; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore.
  • Flegel WA; Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Targoff IN; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences.
  • Miller FW; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD.
  • Lundberg IE; Veteran's Affairs Medical Center, University of Oklahoma Health Sciences Center, and Oklahoma Medical Research Foundation, Oklahoma City, OK.
  • Rider LG; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences.
  • Mammen AL; Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet.
Rheumatology (Oxford) ; 62(SI2): SI226-SI234, 2023 02 23.
Article em En | MEDLINE | ID: mdl-35961028
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatomiosite / Exantema / Miosite Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatomiosite / Exantema / Miosite Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article